Presidents Brief Introduction

Xiantao Ou, Doctor of Business Administration of Zhongshan University, President of Chaoshan Region Alumni Association of School of Management of Zhongshan University,  Vice President of Entrepreneur Alumni Association of Zhongshan University, Vice President of Guangdong Province Pharmaceutical Industry Association. Currently, Mr. Ou serves as CPPCC member of Shantou, Vice Chairman of Shantou Federation of Industry and Commerce (General Chamber of Commerce), Vice President of Guangdong Province Chaoshan Chamber of Commerce, Honorary President of General Chaoshan Chamber of Commerce in the US, Executive Vice President of Guangdong Province Venture Capital Association, business mentor of MBA Education Center of Shantou University, etc.  

Mr. Ou holds nearly ten holding companies, involving three fields: real estate, medicine and capital operation. As a young Chaoshan merchant, Mr. Ou published articles and reviews in professional and economic newspapers and magazines for many times, and he is the author of the book “the Entrepreneur Network Effect on the Access to Capital and the Growth of Start-ups”. As the member of International Teochew Doctors Assocation and the representative of eastern Guangdong private entrepreneurs, Mr. Ou has accepted multiple media interviews, putting forwards his opinions on many issues such as the way of enterprise management, the way to use personnel, the entrepreneurs' social responsibility, the relationship between enterprise and the city etc.

On the real estate sector, adhering to the idea of “accurate positioning, advanced vision”, Mr. Ou has created a number of high-quality real estate projects, which were widely welcomed by the market.

On the medicine sector, Guangdong Wannianqing Pharmaceutical Co., Ltd., which is with more than 60 years of history and integrates R&D, production and sales, is the largest pharmaceutical company in the eastern Guangdong area. The company, equipped with nearly thousand sets of multi-functional equipments, has a modern GMP standard production base and 13 kinds of advanced dosage forms production lines. In 2017, the company has launched IPO process.

On the capital operation sector, Mr. Ou has invested several projects and enterprises including internet and Guangsheng new material, as well as medicine and real estate, achieving considerable social and economic benefit.